INFINITT Healthcare Co., Ltd (071200):企業の財務・戦略的SWOT分析

◆英語タイトル:INFINITT Healthcare Co., Ltd (071200) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0906
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

INFINITT Healthcare Co., Ltd (071200) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

INFINITT Healthcare Co., Ltd. (INFINITT) offers medical imaging and information solutions. The company’s enterprise imaging solutions include radiology information system (RIS), PACS (picture archiving and communication system), cardiology suite, mammography PACS, dental PACS and 3D/advanced visualization software. The services offered by the company include tele-radiology, cloud services, clinical information services, integration and consulting, data migration and remote monitoring services. The company’s products find applications in various areas that include radiology, cardiology, dental, radiation oncology, women’s health, veterinary and others. It has a presence in the US, the UK, Brazil, Germany, Malaysia, China, Japan, Taiwan and other countries. INFINITT is headquartered in Seoul, South Korea.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
INFINITT Healthcare Co., Ltd – Key Facts
INFINITT Healthcare Co., Ltd – Key Employees
INFINITT Healthcare Co., Ltd – Key Employee Biographies
INFINITT Healthcare Co., Ltd – Major Products and Services
INFINITT Healthcare Co., Ltd – History
INFINITT Healthcare Co., Ltd – Company Statement
INFINITT Healthcare Co., Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
INFINITT Healthcare Co., Ltd – Business Description
INFINITT Healthcare Co., Ltd – SWOT Analysis
SWOT Analysis – Overview
INFINITT Healthcare Co., Ltd – Strengths
INFINITT Healthcare Co., Ltd – Weaknesses
INFINITT Healthcare Co., Ltd – Opportunities
INFINITT Healthcare Co., Ltd – Threats
INFINITT Healthcare Co., Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
INFINITT Healthcare Co., Ltd, Key Facts
INFINITT Healthcare Co., Ltd, Key Employees
INFINITT Healthcare Co., Ltd, Key Employee Biographies
INFINITT Healthcare Co., Ltd, Major Products and Services
INFINITT Healthcare Co., Ltd, History
INFINITT Healthcare Co., Ltd, Subsidiaries
INFINITT Healthcare Co., Ltd, Joint Venture
INFINITT Healthcare Co., Ltd, Key Competitors
INFINITT Healthcare Co., Ltd, Ratios based on current share price
INFINITT Healthcare Co., Ltd, Annual Ratios
INFINITT Healthcare Co., Ltd, Annual Ratios (Cont...1)
INFINITT Healthcare Co., Ltd, Annual Ratios (Cont...2)
INFINITT Healthcare Co., Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
INFINITT Healthcare Co., Ltd, Performance Chart (2014 - 2018)
INFINITT Healthcare Co., Ltd, Ratio Charts

★海外企業調査レポート[INFINITT Healthcare Co., Ltd (071200):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Verastem Inc (VSTM):医療機器:M&Aディール及び事業提携情報
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • The Hong Kong and China Gas Company Limited:企業の戦略・SWOT・財務情報
    The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • ImmunoCellular Therapeutics Ltd (IMUC)-医療機器分野:企業M&A・提携分析
    Summary ImmunoCellular Therapeutics Ltd (IMCU) is a clinical-stage biotechnology company which develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product …
  • Texas Municipal Power Agency:企業の戦略的SWOT分析
    Texas Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Linamar Corporation (LNR):企業の財務・戦略的SWOT分析
    Linamar Corporation (LNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mecklenburg Electric Cooperative:企業の戦略的SWOT分析
    Mecklenburg Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • UbiQ Bio BV:製薬・医療:M&Aディール及び事業提携情報
    Summary UbiQ Bio BV (UbiQ) is a biotechnology company that develops and commercializes ubiquitinated peptides and assays that enables drug discovery in Ubiquitin field. The company provides products such as ubiquitin-proteasome system, high throughput screening assay reagents and ubiquitinated polyp …
  • Crew Energy Inc (CR):企業の財務・戦略的SWOT分析
    Summary Crew Energy Inc (Crew Energy) is an exploration and production company that offers our long-term production and development of crude oil and natural gas resources. The company offers exploration, development, strategic acquisitions, operations, management, and production programs. It operate …
  • Ceapro Inc (CZO):製薬・医療:M&Aディール及び事業提携情報
    Summary Ceapro Inc (Ceapro) is a biotechnology company which develops proprietary extraction technologies for use in the production of extracts and active ingredients from oats and other renewable plant resources. The company’s extracts are also used in nutraceutical, cosmeceutical, and therapeutics …
  • Serina Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Serina Therapeutics Inc (Serina Therapeutics) is a drug company that develops therapeutics for cancer, inflammation, pain, and metabolic disorders. The company’s pipeline product includes SER-214, SER-226, SER-228, SER-232, and other proprietary drugs. It uses proprietary technology, polyoxa …
  • Marks and Spencer Group plc (MKS):企業の財務・戦略的SWOT分析
    Marks and Spencer Group plc (MKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • ReWalk Robotics Ltd (RWLK):企業の製品パイプライン分析
    Summary ReWalk Robotics Ltd (ReWalk) is a medical device company that designs, develops and commercializes exoskeletons. The company offers walk restoration devices for people with lower limb disabilities to stand and walk once again. Its products include ReWalk personal system and ReWalk rehabilita …
  • Nishimatsu Construction Co Ltd (1820):企業の財務・戦略的SWOT分析
    Nishimatsu Construction Co Ltd (1820) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • SPX Corporation:企業の戦略・SWOT・財務分析
    SPX Corporation - Strategy, SWOT and Corporate Finance Report Summary SPX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Wincor Nixdorf AG:企業の戦略・SWOT・財務情報
    Wincor Nixdorf AG - Strategy, SWOT and Corporate Finance Report Summary Wincor Nixdorf AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Enterprise Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Enterprise Therapeutics Ltd (Enterprise Therapeutics) is a drug discovery company that offers research and development of novel therapies for the treatment of respiratory diseases. The company also identifies novel targets and compounds which reduces the mucus production. It provides therape …
  • Impel NeuroPharma Inc:医療機器:M&Aディール及び事業提携情報
    Summary Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders. The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delive …
  • Greensmith Energy Management Systems LLC:電力:M&Aディール及び事業提携情報
    Summary Greensmith Energy Management Systems, LLC (Greensmith), a subsidiary of Wartsila Corporation, is a provider of energy storage management and services. The company specializes in software and control solutions to operate and manage Distributed Energy Storage Systems (DESS) for utility-scale, …
  • Zara Investment (Holding) Co Ltd:戦略・SWOT・企業財務分析
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • TherOx Inc:医療機器:M&Aディール及び事業提携情報
    Summary TherOx Inc (TherOx) is a medical device company that develops and commercializes SuperSaturated Oxygen (SSO2) therapies for treatment of heart attack. Its SSO2 therapy is designed to ameliorate progressive myocardial necrosis by minimizing microvascular damage in heart attack patients. TherO …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆